Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etofenamate 5% patch in acute unilateral ankle sprain
2014-001720-30Phase 2Completed
- Sponsor
- Drossapharm
- Start
- Jun 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Ankle sprain comparing Etofenamate 5% patch with Placebo patch (2 arms). Primary endpoint: Ankle pain on movement at 72 hours. Started Jun 2014; status: completed.
02
Drugs
etofenamate
03
Conditions
Ankle sprain
Beyond the preview
Go deeper on 2014-001720-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-001720-30.